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The advent of RNA interference has led to the ability to interfere
with gene expression and greatly expanded our ability to perform
genetic screens in mammalian cells. The expression of short hairpin
RNA (shRNA) from polymerase III promoters can be encoded in
transgenes and used to produce small interfering RNAs that down-
regulate specific genes. In this study, we show that polymerase
II-transcribed shRNAs display very efficient knockdown of gene
expression when the shRNA is embedded in a microRNA context.
Importantly, our shRNA expression system [called PRIME (potent
RNA interference using microRNA expression) vectors] allows for
the multicistronic cotranscription of a reporter gene, thereby
facilitating the tracking of shRNA production in individual cells.
Based on this system, we developed a series of lentiviral vectors
that display tetracycline-responsive knockdown of gene expres-
sion at single copy. The high penetrance of these vectors will
facilitate genomewide loss-of-function screens and is an important
step toward using bar-coding strategies to follow loss of specific
sequences in complex populations.
genetic screen  lentivirus  MAGIC
A new era of eukaryotic genetics began with the discovery ofRNA interference (RNAi), in which dsRNA introduced
into cells silences gene expression of the homologous gene (1, 2).
Upon cell entry, the dsRNA is cleaved by the nuclease Dicer into
double-stranded small interfering RNAs (siRNAs) of 21 nt
length with a two-base 3 overhang. These siRNAs are recog-
nized by the RNA-induced silencing complex (RISC), and
assembly of one siRNA strand into RISC is used to identify
complementary mRNAs, thereby targeting them for destruction
by a second nuclease in the pathway, Ago 2 (reviewed in ref. 3).
In this manner, RNAi allows for the sequence-specific destruc-
tion of mRNAs expressed from both alleles in diploid organisms.
Thus, mutant phenotypes can be generated and explored in
diploids with a speed and precision never before possible.
The discovery of RNAi has led to the development of methods
to exploit these findings for high-throughput genetic analyses (1,
2). Whereas RNAi with long dsRNAs works well for Caeno-
rhabditis elegans and Drosophila melanogaster, it is toxic in most
mammalian cells, presumably because of the activation of anti-
viral responses (1, 2). This toxicity was circumvented when it was
discovered that the siRNAs generated by Dicer cleavage were
able to target complementary cellular mRNAs for destruction
but small enough to evade significant detection by the antiviral
responses (4). A second important development was the finding
that siRNAs could be genetically encoded in an organism by
expressing a short hairpin RNA (shRNA), consisting of a
sequence of 21–29 nt, a short loop region, and the reverse
complement of the 21- to 29-nt region driven by a polymerase
(pol) III promoter such as U6 or H1 (reviewed in refs. 3 and 5).
When transcribed in vivo, this short transcript folds back on itself
to form a hairpin structure, which is converted by endogenous
nucleases (in a manner that is not yet clear) into short RNAs that
are recognized by the RNA-induced silencing complex and used
to target mRNAs for destruction.
The ability to genetically encode shRNAs in cells has led to the
generation by our laboratories and others of collections of
shRNAs expressed from retroviruses that cover large numbers of
mammalian transcripts, with the ultimate goal of targeting every
transcript encoded in the genome of the organism of choice (6,
7). These shRNA libraries have been used to perform genetic
screens in tissue culture cells for a variety of phenotypes
including cell transformation and others (6–8). Although the
current shRNA expression systems show great promise, their
broad applicability is often constrained by a number of limita-
tions. First, most vector systems transcribe the shRNA constructs
under the control of pol III promoters, which are constitutively
expressed in all cell types. There are many examples where
tissue-specific expression of shRNAs (using cell type-specific pol
II promoters) would be desired. Second, many genes are essen-
tial, and therefore constitutively expressed constructs are toxic
to the transduced cells. Having the ability to control the timing
and levels of shRNA expression would be extremely valuable for
a variety of experimental designs and would allow for strict
isogenicity of control experiments. Finally, one of the key
advances in the use of the vector-based shRNA technology is the
ability to use bar coding to deconvolute complex libraries of
virally encoded shRNA for phenotypes of interest (1). However,
this ability rests on the assumption that each viral construct for
a given shRNA will have high penetrance in knocking down its
intended target at single copy.
A number of systems have recently been developed to attempt
regulated shRNA expression from pol II or pol III promoters
(9–13). Upon closer inspection, it becomes apparent that these
systems relied either on transient expression of the vectors or the
integration of multiple copies of the regulatable shRNA con-
struct (ranging from 10 to 100). Importantly, none of the
systems hitherto described has been shown to generate high
penetrance regulatable knockdown at single copy. In this study,
while attempting to use a cre–lox-based inducible shRNA sys-
tem, we discovered an efficient method to express microRNA
(miR)30-based shRNAs from pol II promoters. Based on this
finding, we developed a series of lentiviral vectors (pPRIME,
potent RNAi using miR expression) that provide high pen-
etrance regulatable knockdown at single copy. In addition,
pPRIME allows for the tracking of shRNA expression with a
variety of reporter genes. The pPRIME vectors should facilitate
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functional genomic applications in mammals and provide suffi-
cient penetrance for the use of bar-coding strategies to decon-
volute complex libraries of virally encoded shRNAs.
Materials and Methods
Generation of Plasmids. The miR30-based retinoblastoma (Rb)
targeting sequence (5-AGCAGTTCGATATCTACTGAAA-3)
was designed by using the RNAi design algorithm at http:
katahdin.cshl.org:9331siRNARNAi.cgi?typeshRNA and
cloned into pSM2 as described (14). To generate pSico-miR30, the
PheS-containing mating recipient cassette (15) was PCR-cloned
into the NotI and XhoI site of pSico, and pSM2-Rb was mated with
the pSico–PheS recipient by using the MAGIC cloning protocol (15),
yielding pSico–miR30–Rb. To generate the inducible pPRIME
vectors, we replaced the CMV promoter (XbaIAge1) with the
tetracycline (TET) (pTRE-Tight, Clontech) orTet-repressor-based
expression system (TREX) promoter (pcDNATOlacZ, Invitro-
gen) in pSico–miR30. Theneomycin (Neo), internal ribosomeentry
site–Neo, and low-affinity nerve growth factor receptor (LNGFR)
coding regions were PCR-cloned from pMSCVneo (Clontech),
pQCXIN (Clontech), and pMACS LNGFR (Miltenyi Biotec, Au-
burn, CA), respectively. Detailed vector maps and sequence infor-
mation are available on request.
Cell Culture. HeLa Tet-OFF and 293 TREX cells were cultivated
in DMEM supplemented with 10% Tet-approved FBS. U2OS
Tet-ON and U2OS Tet-OFF cells were cultured in McCoys
medium supplemented with 10% Tet-approved FBS. Doxycy-
cline (DOX) was used at a concentration of 1 gml unless
otherwise specified in the figure legends.
Virus Generation and Infection. Lentiviruses were generated by
cotransfecting 15 g of lentiviral vector and 7.5 g of each
packaging vector (coding for Gag, Pol, Tat, Rev, and VSVG) in
293T cells by using calcium phosphate reagent (Clontech).
Supernatants were collected 48 h after transfection, filtered
through a 0.4-m membrane, and used directly to infect cells.
Unless stated otherwise, cells were infected so that the percent-
age of GFPdsRed-positive cells was 30% to ensure that the
majority of cells contained single proviral integrants. GFP
dsRed-positive cells were sorted 4 days after infection. To isolate
LNGFR-expressing cells, cells were stained with FITC-
conjugated LNGFR antibody (CD271–FITC, Miltenyi Biotec)
and sorted by FACS.
Western Blot Analysis. Equal numbers of cells were lysed in SDS
sample buffer, boiled, sonicated, and loaded onto 4–20% gra-
dient TrisHCl gels (Invitrogen). Western blotting was per-
formed by using anti-Rb (Pharmingen), anti-GFP (Santa Cruz
Biotechnology), and anti-GAPDH (Santa Cruz Biotechnology)
antibodies.
Results
miR30-Based shRNAs Provide Efficient Knockdown When Transcribed
from the Pol II Promoter.We recently developed the pSM2 shRNA
vector, which carries the short hairpins embedded within a
miRNA transcript from the naturally occurring miR30 (14, 23).
We chose miR30 because the processing of the larger pre-
miRNA transcript to its functional miRNA has been well
characterized in vitro and in vivo (reviewed in ref. 16). The pSM2
vector has been designed to allow the replacement of the mature
miR30 encoding region with shRNA sequences that target any
transcript of choice (Fig. 1A) (14, 17). In pSM2, the miR30-based
shRNA is transcribed under the control of the pol III-based U6
promoter. Based on transient transfection assays, the pSM2
vector has been shown to significantly outperform standard short
hairpin vectors such as pSM1 (23).
To test the efficiency of the pSM2 vector in targeting endog-
enous proteins when present at low copy number, we infected
cells with pSM2 virus that contains a sequence targeting the
transcript of the Rb protein (pSM2–Rb). Whereas cells trans-
duced at a multiplicity of infection (MOI) of 2 showed some
reduction Rb protein levels compared with uninfected cells, we
found that cells containing single integrants (MOI1) exhibited
only minimal reduction of Rb protein levels (Fig. 1C). While
attempting to establish a cre-inducible lentiviral vector based on
the miR30-based shRNA expression, we fortuitously discovered
Fig. 1. Pol II-driven miR30-based shRNAs function efficiently at single copy.
(A) Schematic representation of the pSM2 vector structure (see Fig. 6 for
additional information), showing the secondary structure fold of the miR30-
based shRNAs as predicted by RNAFOLD (http:rna.tbi.univie.ac.atcgi-bin
RNAfold.cgi). In pSM2, the region coding for the mature miR30 miRNA (upper
hairpin) is replaced with sequences that encode shRNAs targeting any gene of
choice (shRNA, lower hairpin). The antisense strand, which encodes the tar-
geting siRNA is shown in red. (B) Schematic representation of pSico and
pSico–miR30 before and after Cre-mediated recombination. (C) U2OS cells
were transduced at the indicated MOIs with pSM2 containing an shRNA that
targets the Rb transcript (pSM2–Rb) and cultured for 1 week in puromycin (1
gml)-containing medium. For pSico–miR30, U2OS cells were infected with
the indicated lentivirus (MOI 0.3) and sorted for GFP-positive cells. These
cells were infected with Ad–Cre and sorted for GFP-negative cells 4 days
postinfection. Cell extracts were immunoblotted for Rb and GAPDH (loading
control) protein levels. Uninfected cells serve as control.






a vector system that efficiently down-regulates Rb protein levels
even when present at single copy.
To establish a miR30-based cre-inducible RNAi system we took
advantage of a recently described conditional shRNA lentiviral
vector named pSico (9). pSico contains a modified U6 promoter
interrupted by a loxP-flanked cassette encoding a CMV–GFP gene
(Fig. 1B). The presence of CMV–GFP prevents the U6 promoter
from transcribing short hairpin constructs positioned after the 3
loxP site caused by the absence of a functional U6 promoter (9).
After Cre expression, recombination between the loxP sites
(TATA–LOX) deletes CMV–GFP and places a functional U6
promoter (generated by realignment of the proximal sequence
element and TATA box) adjacent to the shRNA-coding region,
thereby activating RNAi (Fig. 1B). To generate an equivalent
conditional construct for miR30-based hairpins, we replaced the
conventional stem-loop shRNA expressed in pSico with a miR30-
based shRNA targeting the Rb transcript (pSico–miR30–Rb, Fig.
1B). Unexpectedly, the miR30-based derivative behaved in pre-
cisely the oppositemanner as conventional shRNAs expressed from
pSico. Cells transduced with pSico–miR30–Rb and sorted for
GFP-positive cells exhibited significant knockdown of the Rb
protein before infection with Adeno–Cre (Fig. 1C). In contrast,
deleting CMV–GFP by infection with Adeno–Cre and sorting for
GFP-negative cells restored Rb expression to levels found in
uninfected cells (Fig. 1C). Importantly, cells were infected at an
MOI of 0.3 to ensure that the majority of transduced cells contain
single proviral integrants. These findings suggest that single-copy
miR30-based shRNA integrants are much more efficient at reduc-
ing Rb protein levels when transcribed from the CMV promoter
compared with the U6 promoter. It is important to note that the
CMV-driven transcript encodes GFP upstream of miR30. In fact,
the physical linkage of the GFP and miR30–shRNA transcript
provides a very useful feature by marking the cells that experience
knockdown (see below). We named this vector pPRIME and
propose the use of qualifiers following pPRIME to indicate the
nature of the promoter, reporter gene, and the gene targeted by the
shRNA; e.g., pPRIME–CMV–GFP–Rb indicates that the CMV
promoter transcribes GFP and miR30-based shRNA targeting Rb.
Development of Tet-Regulatable pPRIME Vectors. To develop a
regulated miR30-based shRNA system, the CMV promoter was
Fig. 2. Tet-regulatable pPRIME vectors generate highly penetrant knockdown at single copy. (A) Schematic representation of the TREX system. In the absence
of DOX, the Tet repressor (TetR) binds to the Tet-operator binding sites located downstream of CMV’s TATA box, thereby preventing transcription. Binding of
DOX to TetR causes its displacement from the CMV promoter, thus allowing for transcription of the GFP–miR30–shRNA transcript. (B) 293 TREX cells were
transduced with the indicated lentiviruses (MOI 0.4), grown in DOX for 3–4 days, and sorted for GFP-positive cells. Cells were split and grown either in the
presence (DOX) or absence (DOX) of DOX for 1 week. Whole-cell extracts were immunoblotted for Rb, GFP, and GAPDH (loading control). (C) 293 TREX cells
were transduced with the indicated lentiviruses. Cells infected at low MOI (0.4) and high MOI (MOI  5) were grown in DOX for 3–4 days and sorted for
GFP-positive cells. Cells infected at the high MOI were also sorted for the highest 10% of GFP expression levels. Whole-cell extracts were immunoblotted against
Rb, GFP, and GAPDH (loading control). (D) Schematic representation of the Tet-ON system. In the absence of DOX, the reverse tTA (rtTA) does not bind to the
TET promoter. Binding of DOX to rtTA promotes its binding to the TET promoter, thereby initiating the transcription of the GFP–miR30–shRNA transcript. (E)
U2OS Tet-ON cells were transduced with the indicated lentiviruses (MOI0.4), grown in DOX for 3–4 days, and sorted for GFP-positive cells. Cells were treated
and analyzed as described in B. (F) Images of 293 TREX transduced with pPRIME–TREX–GFP–Rb grown either in the absence (Lower) of DOX or the presence of
DOX (induced for 16 h, Upper). (G) Schematic representation of the Tet-OFF system. In the absence of DOX, the tTA is bound to the TET promoter and drives
transcription of the GFP–miR30–shRNA transcript. Binding of DOX to tTA leads to its displacement from the promoter and shutdown of transcription. (H and
I) HeLa Tet-OFF and U2OS Tet-OFF cells were transduced with the indicated lentiviruses (MOI 0.4), treated, and analyzed as described in B.
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replaced with different Tet-responsive pol II-based promoters (18).
First, we replaced the CMV promoter in pPRIME–CMV–GFP
with a Tet-responsive promoter that contains two TET-repressor
binding sites downstreamofCMV’sTATAbox (TREX, Invitrogen,
Fig. 2A), yielding pPRIME–TREX–GFP. 293 cells stably express-
ing theTet repressor (293TREX)were infected by using a lowMOI
to yield single integrants and grown under inducing conditions
(DOX). After sorting for GFP-positive cells, cultures were split
and grown for 1 week either in the presence or absence of DOX.
We found that the expression of themiR30-based shRNAconstruct
was tightly regulated. Cells grown in the presence of DOX showed
a dramatic increase in GFP levels compared with cells grown in the
absence of DOX (Fig. 2 B and F). Importantly, cells induced to
express the construct targeting Rb (miR30–shRb) showed a sig-
nificant reduction ofRb protein levels (Fig. 2B, lane 4), whereas the
same vector lacking miR30–Rb (empty) did not affect Rb levels
(Fig. 2B, lane 2). The fact that the miR30–Rb-containing vector
expresses lower GFP levels than the empty control vector (Fig. 2B,
compare lanes 2 and 4) is probably caused by processing of the
bicistronic transcript for RNAi, thereby creating a less stable GFP
mRNA.
As GFP and miR30–shRNA expression are physically linked
in the pPRIME–TREX–GFP vector, we hypothesized that cells
with higher GFP expression will express high levels of miR30–
shRNA and produce more efficient knockdown of their target
gene. To test this notion, we infected cells at low MOI (MOI 
0.3) and high MOI (MOI  5) and sorted for cells with the
highest GFP levels (Fig. 2C, lane 4). The analysis of Rb levels in
these sorted populations revealed that, as predicted, the amount
of Rb knockdown positively correlates with the amount of GFP
expression. We presume either that the cells in the high GFP
population contain a higher number of integrants or the inte-
gration events occurred in chromosomal locations that allow for
more efficient transcription. Our finding suggests that the knock-
down generated by pPRIME–GFP-based vectors can be maxi-
mized by sorting for the highest GFP-expressing cells.
To explore other regulated promoters, we modified pPRIME to
allow for its regulationwith establishedTet activator (tTA) systems.
We replaced the CMV promoter in pPRIME–CMV–GFP with a
minimal CMV promoter containing seven upstream Tet-operator
sites (Clontech, hence referred to as TET) (18–20), yielding pP-
RIME–TET–GFP. The TET-ON system requires expression of the
reverse tet-controlled transcriptional activator (rtTA), which acti-
vates transcription from the TET promoter in response to DOX
(Fig. 2D) (19, 20). To test pPRIME–TET–GFP–Rb,U2OSTet-ON
cells (stably expressing rtTA)were infected at lowMOI (0.3), sorted
for GFP-positive cells (after a brief induction), and cultured either
in the presence or absence of DOX. As expected, GFP was
expressed only in cells grown in the presence of DOX (induced
state, Fig. 2E, lanes 3 and 4). U2OS Tet-ON cells transduced with
empty pPRIME–TET–GFP failed to reduce Rb levels (Fig. 2E,
lane 3). In contrast, cells expressing miR30–shRb significantly
reduced Rb levels in the induced (DOX, Fig. 2E, lane 4) but not
in the uninduced state (DOX, Fig. 2E, lane 2).
Lastly, we probed pPRIME–TET–GFP–Rb in the TET-OFF
system, which shows inverse responsiveness to DOX compared
with the TET-ON system (Fig. 2G) (18, 19). HeLa Tet-Off cells
stably expressing a WT tTA activate transcription only in the
absence of DOX (Fig. 2G). Importantly, Rb protein levels were
only reduced under inducing conditions (DOX) and in cells
containing the Rb targeting construct (Fig. 2I). We also
observed regulatable knockdown at low MOI (0.3) with
pPRIME–TET–GFP–Rb in U2OS Tet-OFF cells (Fig. 2I).
Furthermore, pPRIME–TET–GFP carrying a shRNA targeting
PTEN was able to generate regulatable knockdown of PTEN
expression (Fig. 5, which is published as supporting information
on the PNAS web site), providing further evidence of the broad
applicability of the pPRIME–TET–GFP system.We consistently
observed a higher degree of Rb knockdown in the TET-OFF
compared with the TET-ON system, presumably because of the
stronger transcriptional induction observed in the TET-OFF
system compared with TET-ON (20, 21). Taken together, our
results show that the pPRIME–TET–GFP system allows for the
controllable suppression of cellular genes both with remarkable
efficacy and without significant leakiness.
It is well established that the amount of viral transcript
generated by single-copy retroviral insertions greatly depends on
the site of integration within the host genome. Therefore, we
generated several clonal isolates of HeLa Tet-OFF cells trans-
duced with pPRIME–TET–GFP–Rb and compared their Rb
protein levels in the induced state (DOX, Fig. 3A). Although
some clones clearly reduced Rb levels more efficiently than
others, we were surprised to find that every clone showed a
significant reduction of Rb levels, providing further evidence of
the high penetrance of the pPRIME–TET–GFP system.We next
defined the kinetics, reversibility, and DOX dose responsiveness
of protein knockdown. We chose clone number one for this
analysis, which we confirmed to contain a single proviral inte-
grant by genomic Southern analysis (data not shown). Rb levels
decreased significantly 2 days after DOX removal (Fig. 3C), and
the knockdown reached completion 4 days postinduction. It is
likely that the kinetics of knockdown depend to a large extent on
the stability of the target protein, as the induction of miR30–
shRNA in response to DOX removal occurs very rapidly (12
h, unpublished observation). Furthermore, we found that it takes
6 days to fully recover WT Rb levels after turning off miR30–
shRb transcription (DOX addition, Fig. 3D), indicating that the
miR30-generated shRNAs remain active for several days.
The dose–response analysis revealed an extreme sensitivity to
DOX control and pointed to the possibility of some modulation
of the extent of gene suppression. Whereas partial Rb down-
regulation was already apparent at 0.1 ngml DOX, maximal
suppression was achieved only at doses 0.01 ngml (Fig. 3B).
It is possible that a less efficient shRNA than the one used in this
Fig. 3. Kinetics and dose–responsiveness of Rb regulation by pPRIME–TET–
GFP–Rb. (A) Clonal isolates of the HeLa Tet-OFF cells expressing pPRIME–Tet–
GFP–Rb (see Fig. 2H) were grown under inducing conditions (DOX) and
immunoblotted for Rb, GAPDH, and GFP protein levels. (B) Tet-OFF clone 1 (see
A) expressing GFP–miR30–Rb was cultured for 1 week in medium containing
the indicated concentration of DOX, and cell extracts were blotted for the
indicated proteins. (C) Tet-OFF clone 1 was cultured for 1 week in the presence
of 1gml DOX (repressing condition). At day 0, the drug was withdrawn from
the culture medium, and cells were harvested at the indicated time points.
Whole-cell extracts were analyzed by Western blotting for the indicated
proteins. (D) Tet-OFF clone 1 was cultured for 1 week under inducing condi-
tions (DOX), followed by addition of DOX at a concentration of 1 gml.
Cells were harvested just before DOX treatment (day 0) and at the indicated
time points. Whole-cell extracts were analyzed by Western blotting for the
indicated proteins.






experiment might allow for an even wider modulation of the
degree of gene knockdown.
pPRIME Vectors Can Accommodate Various Reporter Genes. The
initial pPRIME vectors rely on GFP expression as a molecular
marker for the identification and isolation of shRNA-expressing
cells. To increase the versatility of the pPRIME system, we
examined whether GFP can be replaced with other reporters
without compromising knockdown efficiency. Interestingly,
when we placed the CMV promoter directly upstream of the
miR30–shRNA cassette, Rb knockdown was much less efficient
compared with the GFP-containing vector (Fig. 4, compare
pPRIME–CMV and pPRIME–CMV–GFP). However, when we
replaced GFP with the coding region for dsRed (pPRIME–
CMV–dsRed), Neo (pPRIME–CMV–Neo), or LNGFR (which
encodes LNGFR lacking the cytoplasmic signaling domain), the
Rb knockdown efficiency was similar to the GFP-containing
vector (Fig. 4). Even when we increased the spacing between
CMV and the miR30–shRNA by inserting a Neo cassette
(containing a 5 internal ribosome entry site) downstream of
GFP, Rb knockdown was still very efficient at low MOI (Fig. 4,
pPRIME–CMV–GFP-IRES-Neo).
Discussion
The ability to interfere with gene expression in mammals has
allowed the performance of genetic screens in these cells that had
previously been possible only in lower eukaryotes (1, 2). Thus we
can now envision mammalian gene knockout collections similar to
those available in budding yeast. We, and others, have been
pursuing such strategies and have generated collections of retroviral
vectors constitutively expressing shRNA constructs covering thou-
sands of genes (23). Our initial design incorporated a bar-coding
feature, a 60-nt sequence unique to each vector, that allows the
abundance of each shRNAvector to bemonitoredwithin a complex
mixture by microarray hybridization. This strategy has been used
successfully in lower eukaryotes, andwe recently used it successfully
in a mammalian enrichment screen (8). This strategy can also be
used in relative growth assessment assays or screening for synthetic
lethal relationships. However, the latter types of screens are only
feasible if each shRNA integrant demonstrates high penetrance of
the phenotype. Otherwise, the dynamic range of the signal change
will be too low for statistical significance. While attempting to take
advantage of an inducible pol III shRNA expression system to
express shRNAs embedded in a miR30 context, we discovered that
miR30-based shRNAs could very efficiently be expressed from pol
II promoters such that single-copy proviral integrants provide
high-level knockdown in polyclonal cell populations. In other
words, the pPRIME vectors exhibit the high penetrance required
for efficient functional genomic screens, in particular those using
bar-coding strategies.
The use of pol II promoters to drive miR30 constructs had
been demonstrated previously in transient assays but not in a
single-copy retroviral context (12, 17). Interestingly, when we
placed the CMV promoter directly upstream of miR30, high-
level knockdown was not observed. Only when we inserted the
GFP, dsRed, LNGFR, or Neo-coding region between CMV and
the miR30–shRNA transcript did we see high-level knockdown
(Fig. 4). We interpret this finding to mean that either the spacing
is important or that special enhancing sequences exist in these
coding regions that promote miRNA function. Our observations
are consistent with the recent discovery that many endogenous
miRNAs are transcribed by pol II (22). However, it is important
to note that conventional stem-loop shRNAs, such as those used
in pSico, are not processed into functional siRNAs when tran-
scribed as part of a bicistronic pol II transcript (9).
The PRIME vectors described in this study have several useful
features. First, replacing the CMV with cell type-specific pol II
promoters provides the possibility of tissue-specific expression in
animals. Second, all vectors are lentivirus based, which allows for
the efficient transduction of a broad range of cell types, including
nondividing cells and cells that are hard to infect by retroviruses.
Finally, in contrast to the binary cre–lox system, Tet regulation
allows for the modulation of gene knockdown by varying the
dosage of DOX and exhibits full reversibility.
A limitation of most existing inducible vectors is that the cells
experiencing knockdown are not marked. Thus, a fourth advantage
of the PRIME series is that GFP (or other molecular markers) and
the shRNA are part of a bicistronic transcript, thereby unequivo-
cally marking the shRNA-expressing cells. This feature allows one
to identify cells that experience knockdown within a complex
population of cells, a feature particularly valuable for in vivo animal
studies. Another important feature of the inducible PRIMEvectors
is the ability to sort for reporter-positive cells, which obviates the
need for the time-consuming generation of individual clonal iso-
lates in many experimental settings. Furthermore as some shRNA
expression constructs are silenced aftermultiple passages, the direct
linkage to a reporter gene would allow the selection of populations
maintaining shRNA expression.
Finally, we have adapted pPRIME to the MAGIC cloning
system (15), which allows for the rapid and cost-efficient transfer
of our pSM2 library into different expression contexts (Fig. 6,
which is published as supporting information on the PNAS web
site). For example, the MAGIC system will facilitate the genera-
tion of complex tet-inducible shRNA libraries, which will pro-
vide an invaluable resource for genomewide library screens. In
Fig. 4. pPRIME vectors can accommodate a variety of reporter genes. (A)
Schematic representation of pPRIME–CMV derivatives. For more detailed
vector information see Fig. 6. PGK, phosphoglycerate kinase promoter; IRES,
internal ribosome entry site. (B) U2OS cells were transduced with the indicated
lentiviruses (MOI 0.4, uninfected cells served as control). GFP-, dsRed-, and
LNGFR-expressing cells were FACS-sorted 4 days after infection, and Neo-
expressing cells (CMV, CMV-NEO, and CMV-GIN) were selected with 500gml
G418 for 1 week. Drug selection was withdrawn 1.5 days before harvesting the
cells. Whole-cell extracts were analyzed by immunoblotting for the indicated
proteins.
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a parallel study, Dickins et al. (24) found that miR30-based
shRNAs also generate highly penetrant knockdown when driven
by retroviral LTRs. Together, these efficient knockdown systems
significantly extend and improve our RNAi toolbox for func-
tional genomic studies in mammalian cells.
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